Pipeline and approval signals
Search agency notices, approvals, recalls, and regulatory updates from global authorities.
1,100 of 1,100 tracked regulatory updates from 40 agencies and publishers, page 18 of 22.
Industry Perspective: Finding the Missing Link Between Clinical Trial Interoperability and Operational ExcellenceACRP AssociationACRP CEO Recognized as 2026 Nashville Titan 100 HonoreeACRP AssociationA Visit with Toni Willis, Public Member of ACRPโs Board of TrusteesACRP AssociationBridging the Monitoring Gap: A Structured Framework for Clinical Quality ManagementACRP AssociationNavigating Protocol Amendments: Understanding the Growing Burden and Charting a Path ForwardACRP AssociationEnvisioning eConsent Success (Part I): Measuring Operational Impacts at Clinical Trial SitesACRP AssociationEnvisioning eConsent Success (Part II): Laying Out a Global Interoperability Blueprint for eConsentACRP AssociationDeath by a Thousand Portals: Addressing Technology Fragmentation and Site Burden in Clinical ResearchACRP AssociationClinical Research AvengersโฆAssemble!ACRP AssociationWhy Capable Research Sites Are Still Being Overlooked in Clinical TrialsACRP AssociationWhat Clinical Trial Sites Should Know About Insurance and Indemnification Before Signing a Sponsor AgreementACRP AssociationReal-Time Clinical Trials Need More Than New TechnologyโThey Need a New Operating ModelACRP AssociationFrom Policy to Practice: How the World is Supporting Pediatric ResearchACRP AssociationMaking the Financial Case for Risk-Based Quality Management in Clinical ResearchACRP AssociationStrengthen Your Research Compliance Expertise with HCCA Educational ProgramsACRP AssociationIceland as RMS and national applications โ new slot request portalIMA IcelandWe say goodbye to ima.isIMA IcelandTransition of the Icelandic Medicines Agencyโs Website in Full SwingIMA IcelandMeeting highlights from the Pharmacovigilance Risk Assessment Committee (PRAC) 26 - 29 October 2026European Medicines AgencyEMA closed on All Souls' Day, 2 NovemberEuropean Medicines AgencyAMA and EMA issue joint guidance on Ebola vaccine developmentEuropean Medicines AgencyMeeting highlights from the Committee for Medicinal Products for Human Use (CHMP) 12-15 October 2026European Medicines AgencyEMA recommends authorisation of Rasonque for metastatic pancreatic cancerEuropean Medicines AgencyMeeting highlights from the Committee for Veterinary Medicinal Products (CVMP) 6-8 October 2026European Medicines AgencyClinical trial applications advice pilot becomes permanentEuropean Medicines AgencySCRS Digital Innovation Initiative Launches AI Guidance Framework for SitesSCRS (Clinical Research Sites)2026 SCRS Eagle Awards Presented to Bayer and Medpace for Outstanding Site PartnershipsSCRS (Clinical Research Sites)Jennifer Byrne Honored with 2026 Christine K. Pierre Site Impact AwardSCRS (Clinical Research Sites)Clinical Research Site Community Selects 2026 SCRS Eagle Award FinalistsSCRS (Clinical Research Sites)Clinical Research Site Community Selects 2026 SCRS Eagle Award FinalistsSCRS (Clinical Research Sites)AI Isnโt a Stand-Alone Solution. Letโs Stop Treating It Like One.SCRS (Clinical Research Sites)AI Isnโt a Stand-Alone Solution. Letโs Stop Treating It Like One.SCRS (Clinical Research Sites)Trained, but Not Prepared: The State of Clinical Research Site TrainingSCRS (Clinical Research Sites)Trained, but Not Prepared: The State of Clinical Research Site TrainingSCRS (Clinical Research Sites)How Better Research Site Support Improves Clinical Trial DeliverySCRS (Clinical Research Sites)How Better Research Site Support Improves Clinical Trial DeliverySCRS (Clinical Research Sites)Beyond the Database: Building Relationships That Drive Patient RecruitmentSCRS (Clinical Research Sites)Beyond the Database: Building Relationships That Drive Patient RecruitmentSCRS (Clinical Research Sites)Closed Ticket, Open Problem: How Vendor Handoffs Keep Becoming Site WorkSCRS (Clinical Research Sites)Closed Ticket, Open Problem: How Vendor Handoffs Keep Becoming Site WorkSCRS (Clinical Research Sites)ZAMRA REPRESENTATIVES APPOINTED TO AFRICAN MEDICINES AGENCY TECHNICAL COMMITTEESZambia Medicines Regulatory Authority (ZAMRA)Equitable adoption of medicines in Scotland matters more than ever โ letโs do more to achieve itABPI UKNew research shows varied access to new medicines across ScotlandABPI UKPharmaceutical industry backs Budget move to lift VAT barrier on free-of-charge medicinesABPI UKABPI applauds MHRA Strategy 2030ABPI UKNovo Nordisk ABPI membership restoredABPI UKHow Scotland can turn research into better care for patientsABPI UKGuest article from NHS England: New funding approaches to drive adoption of innovative medicines pilotABPI UKThe Budget is the next test of the government's life sciences ambitions, says the ABPIABPI UKA shared vision for Northern IrelandABPI UK






